02/20/2017
CVS Takes a Shot at Rivals with EpiPen Alternative
CVS/pharmacy is promoting the private-label epinephrine auto-injector it released in January by positioning it as the most affordable option for consumers with life-threatening allergies.
THIS CONTENT IS EXCLUSIVE TO PATH TO PURCHASE INSTITUTE MEMBERS
Join the only professional membership community serving the entire ecosystem of CPG brands, retailers, agencies and solution providers along the path to purchase.
P2PI MEMBERS
Activate your account
JOIN P2PI
Contact us for membership options and pricing
